Mitochondrial Dysfunction in Rheumatoid Arthritis

Biomolecules. 2022 Sep 1;12(9):1216. doi: 10.3390/biom12091216.

Abstract

Rheumatoid arthritis, a chronic autoimmune disease with complex etiology, is characterized by excessive proliferation of synovial cells, massive production of inflammatory cells and cartilage destruction. Studies have shown that mitochondrial dysfunction plays an important role in promoting the occurrence of RA. Mitochondria with normal structure and function are essential for the normal survival of chondrocytes and synovial cells. Once mitochondrial function is destroyed, it will affect the survival, activation and differentiation of immune cells and non-immune cells involved in the pathogenesis of RA, thus leading to the occurrence of RA. However, the mechanism of mitochondrial dysfunction in RA remains unclear. This article reviews the method of mitochondrial dysfunction leading to RA, the effects of mitochondrial dysfunction on immune cells, the etiology of mitochondrial dysfunction in RA, and the pathology of mitochondrial dysfunction in RA. We also outline some drugs that can exert therapeutic effects on RA which are associated with modulating mitochondrial activity. The understanding and summary of mitochondrial dysfunction in RA may provide new research directions for pathological intervention and prevention of RA.

Keywords: mitochondria; rheumatoid arthritis.

Publication types

  • Review
  • Research Support, Non-U.S. Gov't

MeSH terms

  • Arthritis, Rheumatoid* / metabolism
  • Chondrocytes
  • Fibroblasts / metabolism
  • Humans
  • Mitochondria / pathology
  • Synoviocytes*

Grants and funding

This work was supported by grants from: National Natural Science Foundation of China (NO. 81660151) and Natural Science Foundation of Jiangxi Province (NO. 2021BAB206092) to Hong Fenfang; National Natural Science Foundation of China (NO. 82060661, 81660751); Key project of Jiangxi Provincial Department of Education (NO. GJJ218104) to Yangshulong.